Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Utilizing Glycaemic Index: An Investigation of the Glycaemic Profiles and Cognitive Performance Displayed by Type 2 Diabetics Across the Course of a Day in Low and High Glycaemic Conditions
The current study aims to investigate the effects of two GI diets (low vs. high GI) in a sample (25 participants) that has diet controlled type 2 diabetes. This sample has been chosen as those with diabetes have been shown to suffer with poor glucose tolerance, along with the associated deficits such as compromised cognitive function. Therefore, it is expected that differences produced by the two diets on blood glucose concentrations and cognitive performance will be greater than those previously seen. If this is the case after analyzing the results, it will provide a potential strategy (diet) for improving glucose tolerance and cognitive performance in a vulnerable section of the population.
With the introduction of the glycemic index in 1981, which can be defined as a measure of
carbohydrate quality within foods, there has been a wealth of research into its' application
to cognitive function. This research has been based on the theory that the availability of
blood-borne glucose can have an impact on cognitive performance. This is supported by work
that has shown that the brain consumes an immense amount of energy relative to the rest of
the body, but possesses minute stores of glycogen which it could convert into its main energy
source; glucose. This means the brain is reliant on the glucose supplied to it by the blood,
which in turn requires the consumption of foods that can be broken down into glucose.
With this in mind, the vast majority of literature has focussed on the acute effects that
foods differing in glycemic values may have on cognitive function, and have found many
relevant findings such as less cognitive performance decline across the morning for children
who eat a low GI breakfast. This could be explained as a low GI breakfast will contain higher
quality carbohydrates, or in other words; slower absorbing carbohydrates, which would suggest
the brain has access to a steady supply of glucose across the more.
Interesting work in the field of physiology has proposed the presence of a second meal
effect, which can be defined as the glycemic index of a meal having an effect on the glycemic
response to a subsequent meal. Surprisingly, there are very few pieces of psychology
literature that investigate the possibility of a second cognitive meal effect, which is based
on the theory that if a meals' GI can affect the glycemic response to a subsequent meal, then
it may also have an effect on cognitive function. However, research into this has found some
evidence for such an effect.
Although, there has been a wealth of research into the glycemic index as a whole, the
methodology varies greatly from study to study. These problems are most evident when looking
at the times that cognitive function tests are administered. For research based upon a theory
that relies on availability of blood-borne glucose, the times of cognitive testing do not
always align themselves with the time points that the glycemic response indicates are ideal
testing times.
An initial study by the investigators looked to resolve the current lack of consistency
amongst previous research by providing participants with three meals throughout the course of
a day, whilst measuring blood glucose via finger prick. The aim was to identify where the
biggest differences in blood glucose occur when looking at the results of a sample of 24
healthy participants. The time points identified would then provide information as to when
significant differences in cognitive performance throughout the day may be expected.
A second study fed a larger healthy sample (40 participants) the same meals, but also
included a cognitive task battery. Results from the blood glucose concentrations supported
results from study 1, with the two diets producing measureable differences in the glycaemic
profiles produced across a test day. This is another step into potentially producing a diet
that could promote healthy glucose regulation and cognitive function.
The current study aims to investigate the effects of two GI diets (low vs. high GI) in a
sample (25 participants) that has diet controlled type 2 diabetes. This sample has been
chosen as those with diabetes have been shown to suffer with poor glucose tolerance, along
with the associated deficits such as compromised cognitive function. Therefore, it is
expected that differences produced by the two diets on blood glucose concentrations and
cognitive performance will be greater than those previously seen. If this is the case after
analyzing the results, it will provide a potential strategy (diet) for improving glucose
tolerance and cognitive performance in a vulnerable section of the population.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |